South Korean biopharmaceutical firm Celltrion Inc. said Monday that it is accelerating work on a treatment for the novel coronavirus as part of its efforts to address the global pandemic. Celltrion said that it plans to start clinical trials on humans to come up with a treatment for the novel coronavirus within the next six months.
Watch this video for more information.
0 Comments